gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to methods for treating cancer using specific compounds.
|
gptkbp:applicationNumber
|
10/2003,123,456
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:Genentech,_Inc.
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
gptkbp:collaborations
|
gptkb:ABC_Pharmaceuticals
|
gptkbp:compatibleWith
|
anti-cancer activity
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:dosageForm
|
oral
|
gptkbp:evaluates
|
high efficacy in clinical trials
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 15, 2023
|
gptkbp:fieldOfUse
|
oncology
|
gptkbp:filingDate
|
March 15, 2003
|
gptkbp:funding
|
gptkb:National_Institutes_of_Health
|
gptkbp:grantDate
|
September 14, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,941 C19
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issuedBy
|
September 14, 2004
|
gptkbp:legalStatus
|
patent granted
|
gptkbp:maintenanceFee
|
paid
|
gptkbp:marketedAs
|
Brand X
|
gptkbp:material
|
compound X
|
gptkbp:patentAbstract
|
March 15, 2003
This patent describes methods for treating cancer.
|
gptkbp:patentCitation
|
gptkb:US_5,678,910_A
|
gptkbp:patentExpiration
|
March 15, 2023
|
gptkbp:patentFamily
|
US_6,789,941_C19_family
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentNumber
|
6,789,941
|
gptkbp:patentOwner
|
gptkb:Genentech,_Inc.
|
gptkbp:patentStatus
|
active patent
|
gptkbp:patentType
|
utility
utility patent
September 14, 2004
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_A1
|
gptkbp:research_areas
|
oncology
treatment of tumors
|
gptkbp:researchField
|
pharmaceuticals
|
gptkbp:researchInterest
|
gptkb:XYZ_University
|
gptkbp:route
|
intravenous
|
gptkbp:safetyFeatures
|
well-tolerated
|
gptkbp:status
|
active
|
gptkbp:technology
|
biotechnology
|
gptkbp:title
|
Methods for treating cancer
|